Next Article in Journal
Expression Profile of Long Non-Coding RNAs during Early Postnatal Development of Mouse Spinal Cord
Previous Article in Journal
Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland
Previous Article in Special Issue
The Missing “lnc” between Genetics and Cardiac Disease
Open AccessMeeting Report

A Year in the Life of the EU-CardioRNA COST Action: CA17129 Catalysing Transcriptomics Research in Cardiovascular Disease

1
Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 6229 ER Maastricht, The Netherlands
2
Cardiovascular Research Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg
3
Institute for clinical medical research and education, University Hospital Centre Sisters of Charity, Zagreb 10 000, Croatia
4
Biogazelle, 9052 Zwijnaarde, Belgium
5
Integrated BioBank of Luxembourg, L-3555 Dudelange, Luxembourg
6
Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, 25198 Lleida, Spain
7
Institute of Human Genetics, Genetic Epidemiology, University of Münster , 48149 Münster, Germany
8
Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Turkey
9
Department of Pharmacology and Pharmacotherapy, Semmelweis University, H-1085 Budapest, Hungary
10
Pharmahungary Group, H-6722 Szeged, Hungary
11
Centre for Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation, Academy of Athens, 115 27 Athens, Greece
12
Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal
13
Department of Medical Biology, School of Medicine, Yeditepe University, Istanbul 34755, Turkey
14
Department of Biophysics, School of Medicine, Yeditepe University, Istanbul 34755, Turkey
15
Department of Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland
16
Department of Medicine, University of Lausanne Medical School, 1005 Lausanne, Switzerland
17
National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK
18
Molecular Cardiology Laboratory, Policlinico San Donato IRCCS, San Donato Milanese, 20097 Milan, Italy
*
Authors to whom correspondence should be addressed.
Current address: Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg City L-4367, Luxembourg.
Non-Coding RNA 2020, 6(2), 17; https://doi.org/10.3390/ncrna6020017
Received: 27 April 2020 / Accepted: 11 May 2020 / Published: 18 May 2020
(This article belongs to the Collection Regulatory RNAs in Cardiovascular Development and Disease)
The EU-CardioRNA Cooperation in Science and Technology (COST) Action is a European-wide consortium established in 2018 with 31 European country members and four associate member countries to build bridges between translational researchers from academia and industry who conduct research on non-coding RNAs, cardiovascular diseases and similar research areas. EU-CardioRNA comprises four core working groups (WG1–4). In the first year since its launch, EU-CardioRNA met biannually to exchange and discuss recent findings in related fields of scientific research, with scientific sessions broadly divided up according to WG. These meetings are also an opportunity to establish interdisciplinary discussion groups, brainstorm ideas and make plans to apply for joint research grants and conduct other scientific activities, including knowledge transfer. Following its launch in Brussels in 2018, three WG meetings have taken place. The first of these in Lisbon, Portugal, the second in Istanbul, Turkey, and the most recent in Maastricht, The Netherlands. Each meeting includes a scientific session from each WG. This meeting report briefly describes the highlights and key take-home messages from each WG session in this first successful year of the EU-CardioRNA COST Action. View Full-Text
Keywords: COST Action; network; non-coding RNA; cardiovascular disease; translational research; interdisciplinary COST Action; network; non-coding RNA; cardiovascular disease; translational research; interdisciplinary
Show Figures

Figure 1

MDPI and ACS Style

Robinson, E.L.; Gomes, C.P.C.; Potočnjak, I.; Hellemans, J.; Betsou, F.; Gonzalo-Calvo, D.; Stoll, M.; Yilmaz, M.B.; Ágg, B.; Beis, D.; Carmo-Fonseca, M.; Enguita, F.J.; Dogan, S.; Tuna, B.G.; Schroen, B.; Ammerlaan, W.; Kuster, G.M.; Carpusca, I.; Pedrazzini, T.; Emanueli, C.; Martelli, F.; Devaux, Y., on behalf of the EU-CardioRNA COST Action; A Year in the Life of the EU-CardioRNA COST Action: CA17129 Catalysing Transcriptomics Research in Cardiovascular Disease. Non-Coding RNA 2020, 6, 17.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop